Endothelin-1 and -2: Two amino acids matter

Life Sciences

Volumn 91, Issue 13-14, 2012, Pages 607-612

  Compeer, Matthijs G ^a   Suylen, Dennis P L ^a   Hackeng, Tilman M ^a   De Mey, Jo G R ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Agonist dependence; Allosteric modulation of receptor function; Endothelin; Rat resistance arteries; Structure activity relationships

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN A RECEPTOR; LEUCINE; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY ENDOTHELIUM; ARTERY MUSCLE; CHIMERA; CONFERENCE PAPER; CONTROLLED STUDY; ISOLATED ARTERY; MALE; MESENTERIC ARTERY; MYOGRAPHY; NONHUMAN; RAT; RESISTANCE BLOOD VESSEL; SENSITIVITY ANALYSIS; SENSORIMOTOR FUNCTION; VASOMOTOR REFLEX;

AMINO ACID SEQUENCE; ANIMALS; ENDOTHELIN-1; ENDOTHELIN-2; MALE; MESENTERIC ARTERIES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PEPTIDES, CYCLIC; RATS; RATS, INBRED WKY; RECEPTOR, ENDOTHELIN A;

RATTUS;

EID: 84867578532     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.02.011     Document Type: Conference Paper

References (35)

1. H. Arai, S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi Cloning and expression of a cDNA encoding an endothelin receptor Nature 348 1990 730 732
2. G. Bogoni, A. Rizzi, G. Calo, C. Campobasso, P. D'Orleans-Juste, and D. Regoli Characterization of endothelin receptors in the human umbilical artery and vein Br J Pharmacol 119 1996 1600 1604
3. I. Braasch, J.N. Volff, and M. Schartl The endothelin system: evolution of vertebrate-specific ligand-receptor interactions by three rounds of genome duplication Mol Biol Evol 26 2009 783 799
4. V. Breu, K. Hashido, C. Broger, C. Miyamoto, Y. Furuichi, and A. Hayes Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors Eur J Biochem 231 1995 266 270
5. W.J. Chiou, J.L. Wessale, T. von Geldern, T.J. Opgenorth, and J.R. Wu-Wong 'Irreversible' endothelin-1 binding does not prohibit ABT-627 from reversing endothelin-1-induced effects J Cardiovasc Pharmacol 36 2000 S48 S52
6. A. Christopoulos, and T. Kenakin G protein-coupled receptor allosterism and complexing Pharmacol Rev 54 2002 323 374
7. A.P. Davenport International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature Pharmacol Rev 54 2002 219 226
8. J.G. De Mey, M.G. Compeer, P. Lemkens, and M.J. Meens ETA-receptor antagonists or allosteric modulators? Trends Pharmacol Sci 32 2011 345 351
9. L.Y. Deng, J.S. Li, and E.L. Schiffrin Endothelin receptor subtypes in resistance arteries from humans and rats Cardiovasc Res 29 1995 532 535
10. M.V. Donoso, H. Faundez, G. Rosa, A. Fournier, L. Edvinsson, and J.P. Huidobro-Toro Pharmacological characterization of the ETA receptor in the vascular smooth muscle comparing its analogous distribution in the rat mesenteric artery and in the arterial mesenteric bed Peptides 17 1996 1145 1153
11. R. Hilal-Dandan, S. Villegas, A. Gonzalez, and L.L. Brunton The quasi-irreversible nature of endothelin binding and G protein-linked signaling in cardiac myocytes J Pharmacol Exp Ther 281 1997 267 273
12. J.P. Huggins, J.T. Pelton, and R.C. Miller The structure and specificity of endothelin receptors: their importance in physiology and medicine Pharmacol Ther 59 1993 55 123
13. M.M. Hynynen, and R.A. Khalil The vascular endothelin system in hypertension - recent patents and discoveries Recent Pat Cardiovasc Drug Discov 1 2006 95 108
14. M. Ihara, K. Noguchi, T. Saeki, T. Fukuroda, S. Tsuchida, and S. Kimura Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor Life Sci 50 1992 247 255
15. K. Ishikawa, M. Ihara, K. Noguchi, T. Mase, N. Mino, and T. Saeki Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788 Proc Natl Acad Sci U S A 91 1994 4892 4896
16. P. Keov, P.M. Sexton, and A. Christopoulos Allosteric modulation of G protein-coupled receptors: a pharmacological perspective Neuropharmacology 60 2011 24 35
17. C. Ko, M.C. Gieske, L. Al-Alem, Y. Hahn, W. Su, and M.C. Gong Endothelin-2 in ovarian follicle rupture Endocrinology 147 2006 1770 1779
18. J. Lattig, A. Oksche, M. Beyermann, W. Rosenthal, and G. Krause Structural determinants for selective recognition of peptide ligands for endothelin receptor subtypes ETA and ETB J Pept Sci 15 2009 479 491
19. E.R. Levin Endothelins N Engl J Med 333 1995 356 363
20. J.J. Maguire, and A.P. Davenport ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro Br J Pharmacol 115 1995 191 197
21. T. Masaki Historical review: endothelin Trends Pharmacol Sci 25 2004 219 224
22. M.J. Meens, G.E. Fazzi, M.A. van Zandvoort, and J.G. De Mey Calcitonin gene-related peptide selectively relaxes contractile responses to endothelin-1 in rat mesenteric resistance arteries J Pharmacol Exp Ther 331 2009 87 95
23. M.J. Meens, M.G. Compeer, T.M. Hackeng, M.A. van Zandvoort, B.J. Janssen, and J.G. De Mey Stimuli of sensory-motor nerves terminate arterial contractile effects of endothelin-1 by CGRP and dissociation of ET-1/ET(A)-receptor complexes PLoS One 5 2010 e10917
24. M.J. Meens, N.J. Mattheij, J. Nelissen, P. Lemkens, M.G. Compeer, and B.J. Janssen Calcitonin gene-related peptide terminates long-lasting vasopressor responses to endothelin 1 in vivo Hypertension 58 2011 99 106
25. R. Meidan, and N. Levy The ovarian endothelin network: an evolving story Trends Endocrinol Metab 18 2007 379 385
26. S. Mihara, and M. Fujimoto Non-isopeptide-selective endothelin receptors in human Girardi heart cells Life Sci 50 1992 219 226
27. M.J. Mulvany, and C. Aalkjaer Structure and function of small arteries Physiol Rev 70 1990 921 961
28. T. Saeki, M. Ihara, T. Fukuroda, M. Yamagiwa, and M. Yano [Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activity Biochem Biophys Res Commun 179 1991 286 292
29. A. Saito, R. Shiba, M. Yanagisawa, T. Masaki, S. Kimura, and K. Yamada Endothelins: vasoconstrictor effects and localization in canine cerebral arteries Br J Pharmacol 103 1991 1129 1135
30. T. Sakurai, M. Yanagisawa, and T. Masaki Molecular characterization of endothelin receptors Trends Pharmacol Sci 13 1992 103 108
31. M. Schnolzer, P. Alewood, A. Jones, D. Alewood, and S.B. Kent In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences Int J Pept Protein Res 40 1992 180 193
32. S. Takizawa, T. Uchide, J. Adur, T. Kozakai, E. Kotake-Nara, and J. Quan Differential expression of endothelin-2 along the mouse intestinal tract J Mol Endocrinol 35 2005 201 209
33. J.P. Tam, W. Liu, J.W. Zhang, M. Galantino, F. Bertolero, and C. Cristiani Alanine scan of endothelin: importance of aromatic residues Peptides 15 1994 703 708
34. B.A. Wallace, and R.W. Janes The crystal structure of human endothelin-1 and how it relates to receptor binding J Cardiovasc Pharmacol 26 Suppl. 3 1995 S250 S253
35. M. Yanagisawa, H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, and Y. Mitsui A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411 415